Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OncoZenge AB | 40,000 | net | 05 Mar 2021 | tx 2+40,000 |
| Moberg Pharma AB | 21,250 | net | 25 May 2022 | tx 3+21,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 May 2022 | PURCHASE | Moberg Pharma AB | 11,250 | 2.30 SEK | first after silence |
| 05 Mar 2021 | PURCHASE | OncoZenge AB | 20,000 | 10.25 SEK | |
| 19 Feb 2021 | PURCHASE | OncoZenge AB | 20,000 | 0.00 SEK | deriv |
| 10 Feb 2021 | PURCHASE | Moberg Pharma AB | 5,000 | 6.33 SEK | |
| 09 Feb 2021 | PURCHASE | Moberg Pharma AB | 5,000 | 6.16 SEK |
1 purchase reported after at least 12 months of silence — most recent on 25 May 2022.